Miguel Gaspar

Miguel Gaspar is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of antibody technology, holding a total of 5 patents. His work focuses on developing innovative solutions for the treatment of cancer and infectious diseases.

Latest Patents

Among his latest patents is a groundbreaking application titled "Fc binding fragments comprising an OX40 antigen-binding site." This application relates to specific binding members that target OX40, which are crucial in the treatment of various diseases. Another notable patent is for "Antibody molecules that bind CD137 and OX40." This invention describes antibody molecules that can agonize both CD137 and OX40, providing potential therapeutic benefits for diseases such as cancer and infectious diseases.

Career Highlights

Throughout his career, Miguel has worked with notable companies, including Invox Pharma Limited and F-star Therapeutics, Inc. His expertise in antibody technology has positioned him as a key player in the biotechnology sector.

Collaborations

Miguel has collaborated with talented individuals in his field, including Mihriban Tuna and Katy Louise Everett. These partnerships have further enhanced his innovative work and contributed to the advancement of antibody therapies.

Conclusion

Miguel Gaspar's contributions to antibody technology and his innovative patents highlight his role as a leading inventor in the biotechnology industry. His work continues to pave the way for new treatments in the fight against cancer and infectious diseases.

This text is generated by artificial intelligence and may not be accurate.